ReviewGenes2024

Preparing for Patient-Customized N-of-1 Antisense Oligonucleotide Therapy to Treat Rare Diseases.

Harry Wilton-Clark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.